Abstract
It is well established that the two major phenotypic variants of human bladder cancers, the low-grade non-invasive papillary bladder carcinoma (N-Inv-BC) and the high-grade invasive BC (Inv-BC), have different molecular features. For example, compared to 10% in N-Inv-BC, p53 point mutations are found in 70% of Inv-BC. p63 expression is suppressed in aggressive BC. In contrast, more than 70% of N-Inv-BC have FGFR3 mutations compared to the 10% found in Inv-BC. Using well-established human BC cell lines, we found that while Inv-BC cells have a mutator phenotype, N-Inv-BC cells do not. N-Inv-BC cells are proficient in nucleotide excision repair and base excision repair, whereas Inv-BC are deficient in both, and the expression of several DNA repair genes is suppressed in Inv-BC cells. This study aims to understand the role of p63, mutated p53, DNA repair function and cell mutation susceptibility to BC development. Background
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.